Literature DB >> 20962138

Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi.

Kim Mallard1, Ruth McNerney, Amelia C Crampin, Rein Houben, Richard Ndlovu, Lumbani Munthali, Robin M Warren, Neil French, Judith R Glynn.   

Abstract

The occurrence of mixed infections of Mycobacterium tuberculosis is no longer disputed. However, their frequency, and the impact they may have on our understanding of tuberculosis (TB) pathogenesis and epidemiology, remains undetermined. Most previous studies of frequency applied genotyping techniques to cultured M. tuberculosis isolates and found mixed infections to be rare. PCR-based techniques may be more sensitive for detecting multiple M. tuberculosis strains and can be applied to sputum. To date, one study in South Africa has used a PCR approach and suggested that mixed infection could be common. We investigated mixed infections in northern Malawi using two lineage-specific PCR assays targeting the Latin American-Mediterranean (LAM) and Beijing lineages. Compared with spoligotyping, the specificity and sensitivity of both assays was 100%. From 160 culture-positive sputa, mixed LAM and non-LAM strains were detected in 4 sputa belonging to 2 (2.8%) patients. Both patients were HIV positive, with no history of TB. Cultured isolates from both patients showed only LAM by PCR and spoligotyping. In a set of 377 cultured isolates, 4 were mixed LAM and non-LAM. Only one showed evidence of more than one M. tuberculosis strain using IS6110-based restriction fragment length polymorphism (IS6110-RFLP) and spoligotyping analyses. Corresponding sputa for the 4 isolates were unavailable. Mixed Beijing and non-Beijing strains were not detected in this study. Mixed infections appear to be rare in our setting and are unlikely to affect findings based on DNA fingerprinting data. Molecular methods, which avoid the selective nature of culture and target distinct strains, are well suited to detection of mixed infections.

Entities:  

Mesh:

Year:  2010        PMID: 20962138      PMCID: PMC3008455          DOI: 10.1128/JCM.01683-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature.

Authors:  J W Dale; D Brittain; A A Cataldi; D Cousins; J T Crawford; J Driscoll; H Heersma; T Lillebaek; T Quitugua; N Rastogi; R A Skuce; C Sola; D Van Soolingen; V Vincent
Journal:  Int J Tuberc Lung Dis       Date:  2001-03       Impact factor: 2.373

2.  Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.

Authors:  A S de Boer; K Kremer; M W Borgdorff; P E de Haas; H F Heersma; D van Soolingen
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units.

Authors:  P Supply; S Lesjean; E Savine; K Kremer; D van Soolingen; C Locht
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host.

Authors:  M Pavlic; F Allerberger; M P Dierich; W M Prodinger
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data.

Authors:  R M Warren; E M Streicher; S L Sampson; G D van der Spuy; M Richardson; D Nguyen; M A Behr; T C Victor; P D van Helden
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Disruption of coding regions by IS6110 insertion in Mycobacterium tuberculosis.

Authors:  S L Sampson; R M Warren; M Richardson; G D van der Spuy; P D van Helden
Journal:  Tuber Lung Dis       Date:  1999

7.  DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?

Authors:  Judith R Glynn; Malcolm D Yates; Amelia C Crampin; Bagrey M Ngwira; Frank D Mwaungulu; Gillian F Black; Steven D Chaguluka; Donex T Mwafulirwa; Sian Floyd; Caroline Murphy; Francis A Drobniewski; Paul E M Fine
Journal:  J Infect Dis       Date:  2004-08-03       Impact factor: 5.226

8.  Patients with active tuberculosis often have different strains in the same sputum specimen.

Authors:  Robin M Warren; Thomas C Victor; Elizabeth M Streicher; Madalene Richardson; Nulda Beyers; Nicolaas C Gey van Pittius; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

Review 9.  Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control?

Authors:  Marcel A Behr
Journal:  Am J Respir Crit Care Med       Date:  2004-03-01       Impact factor: 21.405

10.  Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi.

Authors:  Judith R Glynn; Saad Alghamdi; Kim Mallard; Ruth McNerney; Richard Ndlovu; Lumbani Munthali; Rein M Houben; Paul E M Fine; Neil French; Amelia C Crampin
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more
  31 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved.

Authors:  Yurena Navarro; Marta Herranz; Laura Pérez-Lago; Miguel Martínez Lirola; Maria Jesús Ruiz-Serrano; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

3.  Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.

Authors:  Chao Zheng; Song Li; Zhongyue Luo; Rui Pi; Honghu Sun; Qingxia He; Ke Tang; Mei Luo; Yuqing Li; David Couvin; Nalin Rastogi; Qun Sun
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

4.  Mycobacterium tuberculosis Beijing Genotype in Western Iran: Distribution and Drug Resistance.

Authors:  Parviz Mohajeri; Sakineh Moradi; Sara Atashi; Abbas Farahani
Journal:  J Clin Diagn Res       Date:  2016-10-01

5.  Isolation and molecular characterization of Mycobacterium tuberculosis from humans and cattle in Namwala District, Zambia.

Authors:  Sydney Malama; John Muma; Musso Munyeme; Grace Mbulo; Adrian Muwonge; Isdore Chola Shamputa; Berit Djønne; Jacques Godfroid; Tone Bjordal Johansen
Journal:  Ecohealth       Date:  2014-05-21       Impact factor: 3.184

6.  Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.

Authors:  David Stucki; Marie Ballif; Matthias Egger; Hansjakob Furrer; Ekkehardt Altpeter; Manuel Battegay; Sara Droz; Thomas Bruderer; Mireia Coscolla; Sonia Borrell; Kathrin Zürcher; Jean-Paul Janssens; Alexandra Calmy; Jesica Mazza Stalder; Katia Jaton; Hans L Rieder; Gaby E Pfyffer; Hans H Siegrist; Matthias Hoffmann; Jan Fehr; Marisa Dolina; Reno Frei; Jacques Schrenzel; Erik C Böttger; Sebastien Gagneux; Lukas Fenner
Journal:  J Clin Microbiol       Date:  2016-05-18       Impact factor: 5.948

Review 7.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

Review 8.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.

Authors:  Charles Vorkas; Dumbani Kayira; Charles van der Horst; Irving Hoffman; Mina Hosseinipour; Creto Kanyemba; Nelson Nguluwe; Tarsizio Chikaonda; Maximina Kalikhoka; Doreen Kalaundi; Dan Namarika; Peter Gilligan; Robert Krysiak
Journal:  Malawi Med J       Date:  2012-06       Impact factor: 0.875

10.  After the bottleneck: Genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection.

Authors:  Amine Namouchi; Xavier Didelot; Ulrike Schöck; Brigitte Gicquel; Eduardo P C Rocha
Journal:  Genome Res       Date:  2012-02-29       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.